Asian expert consensus for the diagnosis and treatment of hypertension-associated left ventricular hypertrophy

introduction Left ventricular hypertrophy (LVH) is an important manifestation of hypertensive organ damage associated with increased ventricular wall thickness, left ventricle mass, and cardiac remodeling. Neurohumoral and hemodynamic factors play important roles in the development of LVH. The heart is the most vulnerable target organ for hypertension, and >30% of patients with hypertension will undergo LVH. The incidence rate is positively correlated with the severity of hypertension.[1]

• Publication year

  2016

• Venue

  Cardiology Plus

• Publication date

  2016-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4103/2470-7511.248356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Recommendationsontheuseofechocardiography in adult hypertension : a report from the European Association of Cardiovascular Imaging ( EACVI ) and the American Society of Echocardiography ( ASE ) †

  2015cited by this paper
• 2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension.

  2015cited by this paper
• Association of electrocardiographic left ventricular hypertrophy with incident cardiovascular disease in Japanese older hypertensive patients.

  2015cited by this paper
• Prevalence and risk factors of abnormal left ventricular geometrical patterns in untreated hypertensive patients

  2014cited by this paper
• Meta-analysis of left ventricular hypertrophy and sustained arrhythmias.

  2014cited by this paper
• Diastolic blood pressure reduction contributes more to the regression of left ventricular hypertrophy: a meta-analysis of randomized controlled trials

  2013cited by this paper
• Comparison of ECG and UGG in diagnosis of essential hypertension with left ventricular hypertrophy

  2013cited by this paper
• Diagnostic approach and differential diagnosis in patients with hypertrophied left ventricles

  2013cited by this paper
• Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies

  2012cited by this paper
• Prevalence of electrocardiographic left ventricular hypertrophy in human hypertension: an updated review

  2012cited by this paper
• Arterial Stiffness Is the Independent Factor of Left Ventricular Hypertrophy Determined by Electrocardiogram

  2012cited by this paper
• [2010 Chinese guidelines for the management of hypertension].

  2011cited by this paper
• Progression from concentric left ventricular hypertrophy and normal ejection fraction to left ventricular dysfunction.

  2011cited by this paper
• Comparison between nebivolol and ramipril in patients with hypertension and left ventricular hypertrophy: a randomized open blinded end-point (PROBE) trial.

  2011cited by this paper
• Additive interaction of metabolic syndrome and chronic kidney disease on cardiac hypertrophy, and risk of cardiovascular disease in hypertension.

  2010influential reference
• The cardiac renin–angiotensin system is responsible for high‐salt diet‐induced left ventricular hypertrophy in mice

  2010cited by this paper
• Sympathetic Nervous System Modulation of Inflammation and Remodeling in the Hypertensive Heart

  2010cited by this paper
• RELATIONSHIP BETWEEN METABOLIC SYNDROME AND LEFT VENTRICULAR REMODELING: INFLUENCE OF GENDER: PP.22.356

  2010cited by this paper
• The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)

  2009cited by this paper
• Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values

  2009cited by this paper
• Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study)

  2009cited by this paper
• Clinical impact of left ventricular hypertrophy and implications for regression.

  2009cited by this paper
• Regression of Left Ventricular Mass by Antihypertensive Treatment: A Meta-Analysis of Randomized Comparative Studies

  2009cited by this paper
• Evidence for improved control of hypertension in Taiwan: 1993–2002

  2008cited by this paper
• Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy and Reduction in Sudden Cardiac Death: The LIFE Study

  2008cited by this paper
• Comparison of different electrocardiographic criteria in detecting left ventricular hypertrophy in obesity patients

  2008cited by this paper
• Left Ventricular Hypertrophy in Severe Obesity: Interactions Among Blood Pressure, Nocturnal Hypoxemia, and Body Mass

  2007cited by this paper
• The burden of blood pressure-related disease: a neglected priority for global health.

  2007cited by this paper
• In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study

  2007cited by this paper
• 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

  2007influential reference
• Angiotensin II Receptor Blockade Reduces New-Onset Atrial Fibrillation and Subsequent Stroke Compared to Atenolol: The Losartan Intervention for End Point Reduction in Hypertension (LIFE) Study

  2006cited by this paper
• Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study

  2005cited by this paper
• Hypertensive Heart Disease

  2005cited by this paper
• Global burden of hypertension: analysis of worldwide data.

  2005cited by this paper
• Analysis of Etiology and Risk Factors of in-patients with Hypertension

  2005cited by this paper
• Neural sympathetic activity in essential hypertension.

  2004cited by this paper
• Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial

  2004cited by this paper
• Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.

  2004cited by this paper
• Left ventricular hypertrophy in hypertensive patients in Indian primary care: prevalence and effect of treatment with sustained release indapamide*

  2004cited by this paper
• Prevalence and determinants of left ventricular hypertrophy and remodelling patterns in hypertensive patients: the St. Petersburg study

  2004cited by this paper
• Prognostic significance of left ventricular mass change during treatment of hypertension.

  2004cited by this paper
• Hypertension and Left Ventricular Hypertrophy : The 4 E Effects of Eplerenone , Enalapril , and Eplerenone / Enalapril in Patients With Essential

  2003cited by this paper
• A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.

  2003cited by this paper
• Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy

  2003cited by this paper
• Atrial Fibrillation in Hypertension: Predictors and Outcome

  2003cited by this paper
• Prevention of high salt diet-induced cardiac hypertrophy and fibrosis by spironolactone.

  2003cited by this paper
• Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.

  2002cited by this paper
• [Prevalence and relevant factors on echocardiographic left ventricular hypertrophy among community-based hypertensive patients in Shanghai].

  2002cited by this paper
• Prevalence of Left Ventricular Hypertrophy in Hypertensive Patients Without and With Blood Pressure Control: Data From the PAMELA Population

  2002cited by this paper
• Change in Diastolic Left Ventricular Filling After One Year of Antihypertensive Treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study

  2002cited by this paper
• Overexpression of endothelial nitric oxide synthase attenuates cardiac hypertrophy induced by chronic isoproterenol infusion.

  2002cited by this paper
• Relationship between home blood pressure and longitudinal changes in target organ damage in treated hypertensive patients.

  2002cited by this paper
• Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy.

  2002cited by this paper
• Link of Nonhemodynamic Factors to Hemodynamic Determinants of Left Ventricular Hypertrophy

  2001cited by this paper
• Regression of Left Ventricular Mass with Captopril and Metoprolol, and the Effects on Glucose and Lipid Metabolism

  2001cited by this paper
• Left ventricular hypertrophy and angiotensin II antagonists.

  2001cited by this paper
• Hypertensive left ventricular hypertrophy: pathophysiological and clinical issues.

  2001cited by this paper
• Reduction of Cardiovascular Risk by Regression of Electrocardiographic Markers of Left Ventricular Hypertrophy by the Angiotensin-Converting Enzyme Inhibitor Ramipril

  2001influential reference
• Continuous Relation Between Left Ventricular Mass and Cardiovascular Risk in Essential Hypertension

  2000cited by this paper
• Therapeutic options in minimizing left ventricular hypertrophy.

  2000cited by this paper
• The Prognostic Significance of Various Electrocardiographic Changes \;in Hypertensive Patients with Left Ventricular Hypertrophy

  1999cited by this paper
• The influence of different antihypertensive drugs on left ventricular hypertrophy in a population sample of elderly men

  1999cited by this paper
• Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death.

  1998cited by this paper
• The natural history of borderline hypertension in a Chinese population

  1997cited by this paper
• Comparison of therapeutic studies on regression of left ventricular hypertrophy.

  1997cited by this paper
• The prognostic characteristics of hypertensive left ventricular hypertrophy in a population with low prevalence of hypertension and low plasma cholesterol.

  1993cited by this paper
• Left ventricular hypertrophy. Its relationship to obesity and hypertension.

  1992cited by this paper
• Left ventricular hypertrophy in black and white hypertensives. Standard electrocardiographic criteria overestimate racial differences in prevalence.

  1992cited by this paper
• Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension.

  1991cited by this paper
• The impact of obesity on left ventricular mass and geometry

  1991cited by this paper
• Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats.

  1991cited by this paper
• Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

  1990cited by this paper
• Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study.

  1989cited by this paper
• Usefulness of echocardiographic left ventricular hypertrophy, ventricular tachycardia and complex ventricular arrhythmias in predicting ventricular fibrillation or sudden cardiac death in elderly patients.

  1988cited by this paper
• Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men.

  1986cited by this paper
• Sensitivity of electrocardiographic criteria for left ventricular hypertrophy according to type of cardiac disease.

  1985cited by this paper
• Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy.

  1984cited by this paper
• Abnormalities in the coronary circulation that occur as a consequence of cardiac hypertrophy.

  1983cited by this paper
• The Life Study

  1973cited by this paper
• Asthma: Lessons from Epidemiology

  1973cited by this paper
• Atrial fibrillation in dogs.

  1971cited by this paper
• Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study.

  1970cited by this paper
• Electrocardiographic changes of left ventricular hypertrophy: effects of antihypertensive treatment.

  1957cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Prevalence and Prediction of Obesity among Yemeni Hypertensive Patients: A Single-Center, Cross-Sectional Study

  2023cites this paper
• Correlations of circulating miR-26b level with left ventricular hypertrophy and cardiac function in elderly patients with hypertension

  2021cites this paper
• FACTORS ASSOCIATED WITH LEFT VENTRICULAR HYPERTROPHY IN ADULTS LIVING AT A HIGH ALTITUDE CITY IN PERU

  2021cites this paper